^
Association details:
Biomarker:No biomarker
Cancer:Marginal Zone Lymphoma
Drug:Leukeran (chlorambucil) (Alkylating agent)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Marginal Zone Lymphoma: First-line therapy for elderly or infirm…Other recommended regimens…Chlorambucil ± rituximab